Lung Cancer Screening: Current Status in the United States
Author Information
Author(s): DENIS A. CORTESE
Primary Institution: Mayo Medical School Mayo Clinic Jacksonville
Hypothesis
Does screening with sputum cytology and chest x-ray reduce mortality from lung cancer?
Conclusion
Screening with sputum cytology and chest x-ray did not reduce lung cancer mortality despite identifying more early-stage cancers.
Supporting Evidence
- More cancers were detected in the screened group, but mortality rates were similar.
- Only 9% of patients had cancer detected by sputum cytology alone.
- Less than 13% of patients had resectable cancers when they presented with symptoms.
Takeaway
Doctors checked people's lungs more often, but it didn't help them live longer.
Methodology
The study compared lung cancer detection and mortality rates between groups screened every 4 months and those screened annually.
Potential Biases
Potential overdiagnosis of clinically unimportant cancers.
Limitations
The study had a small sample size and may not have had enough power to detect a significant difference in mortality.
Participant Demographics
Patients enrolled at Mayo Clinic, ages not specified.
Statistical Information
P-Value
0.052
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website